ValiRx plc (EAJF) Ratios
ValiRx plc Ratios
DE:EAJF's free cash flow for Q2 2026 was $-840.33K. For the 2026 fiscal year, DE:EAJF's free cash flow was increased by $0.00 and operating cash flow was $-840.33K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.62 | 5.50 | 2.64 | 11.48 | 11.73 |
| Quick Ratio | 4.33 | 5.30 | 2.32 | 11.48 | 11.73 |
| Cash Ratio | 3.37 | 4.51 | 0.81 | 8.92 | 8.70 |
| Solvency Ratio | -8.49 | -4.76 | -7.87 | -14.58 | -12.03 |
| Operating Cash Flow Ratio | -6.42 | -4.59 | -8.26 | -13.42 | -18.48 |
| Short-Term Operating Cash Flow Coverage | -1082.54 | -151.34 | -173.54 | -171.88 | -130.94 |
| Net Current Asset Value | $ 850.86K | $ 1.55M | $ 339.97K | $ 1.31M | $ 690.46K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Financial Leverage Ratio | 0.92 | 0.99 | 0.97 | 0.98 | 0.98 |
| Debt Service Coverage Ratio | -434.18 | -147.60 | -127.74 | -141.16 | -106.17 |
| Interest Coverage Ratio | -547.62 | -1674.49 | -520.15 | -475.33 | -606.81 |
| Debt to Market Cap | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.36 | 0.83 | 0.07 | 0.46 | 0.37 |
| Profitability Margins | |||||
| Gross Profit Margin | -19.92% | -436.41% | -2562.95% | 0.00% | 0.00% |
| EBIT Margin | -7688.42% | -4277.60% | -23943.11% | 0.00% | 0.00% |
| EBITDA Margin | -6939.28% | -3741.20% | -21295.17% | 0.00% | 0.00% |
| Operating Profit Margin | -5809.21% | -4302.70% | -23943.11% | 0.00% | 0.00% |
| Pretax Profit Margin | -7699.03% | -4280.17% | -23989.15% | 0.00% | 0.00% |
| Net Profit Margin | -7115.13% | -3848.71% | -21226.05% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -7296.26% | -4023.62% | -22164.43% | 0.00% | 0.00% |
| Net Income Per EBT | 92.42% | 89.92% | 88.48% | 92.59% | 92.06% |
| EBT Per EBIT | 132.53% | 99.48% | 100.19% | 100.21% | 100.16% |
| Return on Assets (ROA) | -84.82% | -44.95% | -65.09% | -60.52% | -43.91% |
| Return on Equity (ROE) | -78.18% | -44.37% | -63.31% | -59.40% | -42.99% |
| Return on Capital Employed (ROCE) | -76.05% | -54.68% | -78.83% | -67.39% | -48.55% |
| Return on Invested Capital (ROIC) | -72.03% | -51.26% | -72.58% | -62.14% | -44.47% |
| Return on Tangible Assets | -179.20% | -90.00% | -251.85% | -163.74% | -190.24% |
| Earnings Yield | -161.13% | -187.58% | -34.00% | -22.23% | -6.57% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.14 | 0.49 | 0.10 | 0.00 | 0.00 |
| Payables Turnover | 0.29 | 1.81 | 2.05 | 8.99 | 17.52 |
| Inventory Turnover | 0.55 | 3.87 | 3.70 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.24 | 0.25 | 0.04 | 0.00 | 0.00 |
| Asset Turnover | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.03 | 0.05 | 0.01 | 0.00 | 0.00 |
| Cash Conversion Cycle | 2039.47 | 641.15 | 3686.53 | -40.61 | -20.83 |
| Days of Sales Outstanding | 2621.86 | 748.77 | 3765.96 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 669.42 | 94.33 | 98.52 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1251.82 | 201.95 | 177.95 | 40.61 | 20.83 |
| Operating Cycle | 3291.29 | 843.09 | 3864.48 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.01 | -0.02 | -0.02 | -0.02 |
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.02 | -0.02 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | -111.20 | -41.54 | -5.79 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -111.20 | -41.54 | -5.79 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -1082.54 | -133.61 | -80.31 | -45.40 | -21.47 |
| Operating Cash Flow to Sales Ratio | -48.14 | -31.84 | -184.62 | 0.00 | 0.00 |
| Free Cash Flow Yield | -109.99% | -158.92% | -34.68% | -15.82% | -5.35% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.62 | -0.53 | -2.94 | -4.50 | -15.23 |
| Price-to-Sales (P/S) Ratio | 44.16 | 20.52 | 624.23 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.49 | 0.24 | 1.86 | 2.67 | 6.55 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.91 | -0.63 | -2.88 | -6.32 | -18.69 |
| Price-to-Operating Cash Flow Ratio | -0.92 | -0.64 | -3.38 | -6.32 | -18.69 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.02 | 0.08 | -0.15 | 0.40 |
| Enterprise Value Multiple | -0.27 | 0.28 | -2.86 | -4.10 | -15.89 |
| Enterprise Value | 595.08K | -522.87K | 5.84M | 9.72M | 23.03M |
| EV to EBITDA | -0.27 | 0.28 | -2.86 | -4.10 | -15.89 |
| EV to Sales | 18.97 | -10.50 | 608.34 | 0.00 | 0.00 |
| EV to Free Cash Flow | -0.39 | 0.32 | -2.81 | -5.68 | -18.27 |
| EV to Operating Cash Flow | -0.39 | 0.33 | -3.30 | -5.68 | -18.27 |
| Tangible Book Value Per Share | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 |
| Shareholders’ Equity Per Share | 0.01 | 0.03 | 0.03 | 0.05 | 0.06 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.05 | 0.06 | 0.08 | 0.07 | 0.08 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.01 | -0.01 | -0.02 | -0.03 | -0.02 |
| Tax Burden | 0.92 | 0.90 | 0.88 | 0.93 | 0.92 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 7.31 | 4.93 | 39.93 | 0.00 | 0.00 |
| SG&A to Revenue | 50.58 | 39.70 | 196.50 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 3.85 | 0.00 | 0.00 |
| Income Quality | 0.62 | 0.74 | 0.77 | 0.66 | 0.75 |
Currency in GBP